Setting the scene in Scotland Webinar. Chaired by Prof Gordon Cook; includes: Prof Graham Jackson: Results from ICARIA-MM: Multinational Clinical Study Comparing Isatuximab in combination with Pomalidomide and Dexamethasone; to Pomalidomide and Dexamethasone in Adult Patients with RRMM including a focus on renal impairment subgroup data. Dr Kenny Douglas & Dr Richard Beatson and Dr Jane Clark: Real World Case Studies discussion of practical considerations in treating the RRMM patient population. Q&A session.
Founded in 1981 in Boston, Massachusetts, EuroAPI evolved from a tiny start-up to one of the world's leading biotech companies, with nearly 10,000 employees and operations in every region of the globe. Acquired by Sanofi in 2011, EuroAPI UK now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.
